Sinofn Health
Sinofn Health
In the global nutraceutical landscape, "Nutrient Reference Values" (NRV) serve as the bedrock of regulatory compliance and consumer safety. For brands aiming to expand internationally, understanding the delta between Chinese GB standards, EU EFSA guidelines, and US FDA Daily Values is critical. SINOFN Health integrates these regulatory insights directly into the R&D phase.
China has evolved from a simple manufacturing hub to a high-tech innovation center. SINOFN leverages this by partnering with the Chinese Academy of Sciences (CAS), ensuring that every product—whether it's NMN, Creatine, or personalized PKU foods—is backed by biochemical research rather than just commodity blending. We prioritize bio-availability and ingredient purity over mere volume.
The modern consumer demands "Clean Label" products with verifiable nutrient profiles. Our ODM process focuses on transparency, utilizing blockchain-based batch tracking and rigorous HPLC contaminant screening. We help global brands transition from generic offerings to specialized wellness solutions.
Founded in 2012, SINOFN was born from a clinical necessity: creating affordable, high-quality PKU nutrition. This patient-first philosophy defines our manufacturing standards. When we produce supplements for global partners, we apply the same "Medical Grade" rigor used in our specialized clinical foods.
Our regulatory team audits your target market’s NRV requirements (e.g., EU vs US vs Asia) during the formulation stage to prevent labeling compliance issues.
Absolutely. We operate pilot-scale prototyping lines that allow for testing bioavailability and stability without the need for massive initial capital investment.
The collaboration with the Chinese Academy of Sciences provides our R&D team with access to cutting-edge biochemical data, enabling us to optimize nutrient delivery systems (e.g., liposomal delivery, sustained-release).
